Craft

Nyxoah

Stock Price

$9.5

2024-10-29

Market Capitalization

$365.9 M

2024-10-29

Revenue

€10 M

FY, 2025

Nyxoah Summary

Company Summary

Overview
Nyxoah is a medical device company, engaged in developing diagnostic and therapeutic solutions to combat sleep-disordered breathing conditions. It offers the Genio system, a bilateral neurostimulation therapy to treat moderate to severe obstructive sleep apnea.
Type
Public
Status
Active
Founded
2008
HQ
Mont-Saint-Guibert, BE | view all locations
Website
http://www.nyxoah.com/
Cybersecurity rating
Sectors

Key People

LocationsView all

1 location detected

  • Mont-Saint-Guibert, Wallonie HQ

    Belgium

    Rue Edouard Belin 12

Nyxoah Financials

Summary Financials

Revenue (Q1, 2026)
€6.4M
Gross profit (Q1, 2026)
€3.8M
Net income (Q1, 2026)
(€15.9M)
Cash (Q1, 2026)
€12.9M
EBIT (Q1, 2026)
(€20.5M)
Enterprise value
$386.9M

Footer menu